ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,534, issued on Feb. 17, was assigned to ELI LILLY AND COMPANY (Indianapolis).
"Therapeutic uses of tirzepatide" was invented by Axel Haupt (Zionsville, Ind.), Masahiro Murakami (Carmel, Ind.) and Jeffrey Scott Riesmeyer (Fishers, Ind.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to methods for treating, preventing or delaying disorders relating to cognition, such as cognitive decline, cognitive impairment or dementia. The present invention also relates to method for treating, preventing or delaying heart failure, such as heart failure with preserved ejection fraction (HFpEF) or heart failure with reduced ejection frac...